718: Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines (N)

LEARNING OBJECTIVES

Upon successful completion of this continuing education module, you will be able to:

1. Aerosol Delivery of Short-Acting ß2-Agonists in the Hospital ED
2. Aerosol Delivery of Short-Acting ß2-Agonists in the Inpatient Hospital Setting
3. Intermittent vs Continuous Nebulizer Delivery of ß2-Agonists
4. Short-Acting ß2-Agonists for Asthma in the Outpatient Setting
5. Inhaled Corticosteroids for Asthma
6. ß2-Agonists and Anticholinergic Agents for COPD